February 27, 2020 / 3:06 PM / 3 months ago

BRIEF-GSK Says Filing Accepted By EMA For Trelegy Ellipta Use In Adult Patients With Asthma

Feb 27 (Reuters) - GlaxoSmithKline PLC:

* GSK FILING ACCEPTED BY EUROPEAN MEDICINES AGENCY FOR TRELEGY ELLIPTA USE IN ADULT PATIENTS WITH ASTHMA

* SUBMISSION SUPPORTED BY PIVOTAL CAPTAIN STUDY SHOWING SIGNIFICANT IMPROVEMENT IN LUNG FUNCTION COMPARED WITH ICS/LABA, RELVAR/BREO ELLIPTA

* REGULATORY APPLICATIONS ALSO SUBMITTED FOR TRELEGY DUPLICATE LICENCES, ELEBRATO ELLIPTA, TEMYBRIC ELLIPTA Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below